Quanterix Corp (NAS:QTRX)
$ 12.47 0.41 (3.4%) Market Cap: 478.59 Mil Enterprise Value: 221.31 Mil PE Ratio: 0 PB Ratio: 1.42 GF Score: 70/100

Quanterix Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2021 / 07:50PM GMT
Release Date Price: $67.17 (+8.37%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Sorry, some mute problems there. I am Matt Sykes, the life sciences tools and diagnostics analyst at Goldman Sachs. I have the pleasure of welcoming Quanterix to our conference this afternoon. We have Kevin Hrusovsky, the Chairman and Chief Executive Officer of Quanterix. Kevin, thanks so much for joining us.

E. Kevin Hrusovsky
Quanterix Corporation - Chairman & CEO

Our pleasure, Matt. Thank you.

Questions & Answers

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Great. And I thought maybe I'd just turn it over to you to just briefly. Just maybe talk about -- set the stage and maybe talk a little bit about Quanterix, the platform, and where you see the company sort of in the near and long term?

E. Kevin Hrusovsky
Quanterix Corporation - Chairman & CEO

Absolutely. Thanks, Matt. Yes, we're a disruptive technology company that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot